Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ · Healthcare
Ionis Pharmaceuticals, Inc. Operating Income 2008–2025
Ionis Pharmaceuticals, Inc. annual/quarterly operating income history and growth rate from 2008 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Ionis Pharmaceuticals, Inc. operating income for the quarter ending March 31, 2026 was -117.4 M, a 20.04% decrease year-over-year.
- Ionis Pharmaceuticals, Inc. operating income for the twelve months ending March 31, 2026 was -284.6 M, a 43.91% decrease year-over-year.
- Ionis Pharmaceuticals, Inc. annual operating income for 2025 was -381.7 M, a 19.66% decrease from 2024.
- Ionis Pharmaceuticals, Inc. annual operating income for 2024 was -475.1 M, a 34.31% increase from 2023.
- Ionis Pharmaceuticals, Inc. annual operating income for 2023 was -353.7 M, a 13.76% decrease from 2022.
- Ionis Pharmaceuticals, Inc. annual operating income for 2022 was -410.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ionis Pharmaceuticals, Inc. Operating Income — FAQ
Ionis Pharmaceuticals, Inc. (IONS) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is Ionis Pharmaceuticals, Inc.'s operating income?
Ionis Pharmaceuticals, Inc. (IONS) reported operating income of -$382M for fiscal 2025.
Where can I see IONS's operating income history?
The chart and table above show Ionis Pharmaceuticals, Inc.'s operating income by year and by quarter, including the growth rate.